Revolutionary Handheld Brain Injury Scanner Developed in India for Rapid Diagnosis

Traumatic brain injuries (TBI) represent a major public health concern, especially in rural and underserved regions where access to advanced diagnostic tools such as CT or MRI scans is limited or delayed. Addressing this critical gap, India has pioneered the development of a handheld, portable brain injury scanner named CEREBO, capable of rapidly detecting intracranial bleeding and edema, promising to revolutionize emergency brain injury care.

The device, developed entirely in India at an IIT incubator with support from the Indian Council of Medical Research (ICMR), leverages near-infrared spectroscopy combined with machine learning algorithms. Dr. Rajeev Bahl, Director General of ICMR, explained that this innovative technology utilizes infrared waves to non-invasively scan different parts of the patient’s head, providing instant visual feedback on the presence of brain bleeding.

Unlike traditional assessment methods such as the Glasgow Coma Scale (GCS), which can be subjective and error-prone, or advanced imaging technologies that demand expensive infrastructure and skilled technicians, CEREBO offers a rapid, cost-effective, and radiation-free alternative. The scanner can deliver color-coded results within a minute, enabling frontline healthcare providers to make more informed and timely decisions in emergency settings.

CEREBO’s design targets a broad deployment scope including ambulances, trauma centers, rural clinics, and disaster response units, where timely brain injury diagnosis significantly impacts patient outcomes. The device’s portability and ease of use overcome significant barriers faced in rural healthcare, where delayed diagnosis often worsens TBI prognoses.

This breakthrough emerged from a collaboration between ICMR’s Molecular Diagnostics and Medical Systems division (MDMS), AIIMS Bhopal, NIMHANS Bengaluru, and Bioscan Research. It has successfully undergone clinical validation, regulatory approvals, and health technology assessments proving its efficacy, cost-effectiveness, and feasibility for widespread use.

From a public health perspective, the introduction of CEREBO could reduce treatment delays for brain injuries, decrease unnecessary referrals, optimize resource allocation, and ultimately improve survival rates and long-term neurological outcomes. It also presents potential advantages in military and disaster response healthcare scenarios globally.

While promising, experts urge cautious optimism pending wider real-world application and continuous monitoring. Limitations such as device sensitivity in detecting certain injury types, operator training requirements, and integration into existing healthcare workflows need further evaluation. Dr. Anil Kumar, a neurologist unaffiliated with the device development, noted that while the technology is exciting, rigorous comparative effectiveness research with standard imaging is essential before broad clinical adoption.

For the general public and healthcare practitioners, CEREBO represents a significant step toward accessible, rapid brain injury diagnostics that could transform emergency care delivery in resource-limited settings.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References:

1. Economic Times Health. “Revolutionary handheld brain injury scanner developed in India for rapid diagnosis.” August 2025.